CORT vs. ETN
Compare and contrast key facts about Corcept Therapeutics Incorporated (CORT) and Eaton Corporation plc (ETN).
Performance
CORT vs. ETN - Performance Comparison
Loading graphics...
CORT vs. ETN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 15.83% | -30.94% | 55.14% | 59.92% | 2.58% | -24.31% | 116.20% | -9.43% | -26.02% | 148.76% |
ETN Eaton Corporation plc | 12.64% | -2.79% | 39.51% | 56.22% | -7.18% | 46.70% | 29.88% | 42.76% | -10.04% | 21.54% |
Fundamentals
CORT:
$0.88
ETN:
$10.47
CORT:
45.97
ETN:
34.18
CORT:
22.90
ETN:
1.86
CORT:
6.52
ETN:
5.09
CORT:
$741.17M
ETN:
$27.45B
CORT:
$727.78M
ETN:
$10.32B
CORT:
$72.46M
ETN:
$5.90B
Returns By Period
In the year-to-date period, CORT achieves a 15.83% return, which is significantly higher than ETN's 12.64% return. Over the past 10 years, CORT has outperformed ETN with an annualized return of 23.92%, while ETN has yielded a comparatively lower 21.71% annualized return.
CORT
- 1D
- 5.75%
- 1M
- 12.91%
- YTD
- 15.83%
- 6M
- -51.50%
- 1Y
- -64.71%
- 3Y*
- 23.00%
- 5Y*
- 10.53%
- 10Y*
- 23.92%
ETN
- 1D
- 4.12%
- 1M
- -4.56%
- YTD
- 12.64%
- 6M
- -3.87%
- 1Y
- 33.19%
- 3Y*
- 29.57%
- 5Y*
- 22.72%
- 10Y*
- 21.71%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CORT vs. ETN — Risk / Return Rank
CORT
ETN
CORT vs. ETN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Eaton Corporation plc (ETN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CORT | ETN | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.82 | 0.97 | -1.79 |
Sortino ratioReturn per unit of downside risk | -0.96 | 1.49 | -2.46 |
Omega ratioGain probability vs. loss probability | 0.82 | 1.20 | -0.37 |
Calmar ratioReturn relative to maximum drawdown | -0.36 | 1.68 | -2.04 |
Martin ratioReturn relative to average drawdown | -0.58 | 3.74 | -4.32 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CORT | ETN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.82 | 0.97 | -1.79 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.14 | 0.78 | -0.64 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.36 | 0.73 | -0.38 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.07 | 0.41 | -0.34 |
Correlation
The correlation between CORT and ETN is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
CORT vs. ETN - Dividend Comparison
CORT has not paid dividends to shareholders, while ETN's dividend yield for the trailing twelve months is around 1.18%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ETN Eaton Corporation plc | 1.18% | 1.31% | 1.13% | 1.43% | 2.06% | 1.76% | 1.88% | 3.00% | 3.85% | 3.04% | 3.40% | 4.23% |
Drawdowns
CORT vs. ETN - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.28%, which is greater than ETN's maximum drawdown of -68.95%. Use the drawdown chart below to compare losses from any high point for CORT and ETN.
Loading graphics...
Drawdown Indicators
| CORT | ETN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.28% | -68.95% | -25.33% |
Max Drawdown (1Y)Largest decline over 1 year | -65.03% | -19.14% | -45.89% |
Max Drawdown (5Y)Largest decline over 5 years | -71.85% | -34.46% | -37.39% |
Max Drawdown (10Y)Largest decline over 10 years | -71.85% | -44.55% | -27.30% |
Current DrawdownCurrent decline from peak | -64.71% | -9.42% | -55.29% |
Average DrawdownAverage peak-to-trough decline | -53.45% | -14.93% | -38.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 45.10% | 8.57% | +36.53% |
Volatility
CORT vs. ETN - Volatility Comparison
Corcept Therapeutics Incorporated (CORT) has a higher volatility of 21.99% compared to Eaton Corporation plc (ETN) at 11.84%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than ETN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CORT | ETN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.99% | 11.84% | +10.15% |
Volatility (6M)Calculated over the trailing 6-month period | 85.27% | 23.36% | +61.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 134.82% | 34.34% | +100.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 73.97% | 29.20% | +44.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 67.09% | 29.65% | +37.44% |
Financials
CORT vs. ETN - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Eaton Corporation plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CORT vs. ETN - Profitability Comparison
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Corcept Therapeutics Incorporated reported a gross profit of 203.04M and revenue of 207.64M. Therefore, the gross margin over that period was 97.8%.
ETN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Eaton Corporation plc reported a gross profit of 2.60B and revenue of 7.06B. Therefore, the gross margin over that period was 36.8%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Corcept Therapeutics Incorporated reported an operating income of 10.22M and revenue of 207.64M, resulting in an operating margin of 4.9%.
ETN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Eaton Corporation plc reported an operating income of 1.38B and revenue of 7.06B, resulting in an operating margin of 19.5%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Corcept Therapeutics Incorporated reported a net income of 19.36M and revenue of 207.64M, resulting in a net margin of 9.3%.
ETN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Eaton Corporation plc reported a net income of 1.13B and revenue of 7.06B, resulting in a net margin of 16.1%.